Sweden· SE-19740614000055
Synacthen 0,25 mg/ml Injektions-/infusionsvätska, lösning
A medicinal product containing tetracosactide, registered in Sweden by Alfasigma S.P.A..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Tetracosactide
- Manufacturer
- Alfasigma S.P.A.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19740614000055
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tetracosactide in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCortrosynHenry Schein, Inc.
- United KingdomSynacthen 250micrograms/1ml solution for injection ampoulesAtnahs Pharma UK Ltd
- NorwaySynacthenAlfasigma S.p.A
- CanadaCORTROSYN INJ 0.25MGAMPHASTAR PHARMACEUTICALS, INC.
- SpainNUVACTHEN DEPOT 1MG/ML SUSPENSIÓN INYECTABLEAlfasigma S.P.A.
- NetherlandsSynacthen 0,25 mg/ml, oplossing voor injectie of infusieAlfasigma S.p.A.
- SwitzerlandSynacthen, InjektionslösungAtnahs Pharma Switzerland AG
- Japanテトラコサクチド酢酸塩アルフレッサファーマ
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Austria · Synacthen Ampulle, Synacthen Depot
- Belgium · Synacthen, Synacthen Depot
- Denmark · Synacthen
- France · Synacthene, Synacthene Retard
- Ireland · Synacthen
- Italy · Synacthen
- Luxembourg · Synacthen, Synacthen Dépôt
- Netherlands · Synacthen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f332a118-aa08-4efb-9335-224dd53230c2 GET /v1/drugs/f332a118-aa08-4efb-9335-224dd53230c2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "19740614000055",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19740614000055",
"product_doc_link": "https://docetp.mpa.se/LMF/Synacthen%20Solution%20for%20injection%20or%20infusion%20SmPC_09001bee8186e2de.pdf"
}See everything about tetracosactide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.